9RF2
M. tuberculosis meets European Lead Factory: identification and structural characterization of novel Rv0183 inhibitors using X-ray crystallography: ELF5
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | PETRA III, DESY BEAMLINE P11 |
Synchrotron site | PETRA III, DESY |
Beamline | P11 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2022-11-22 |
Detector | DECTRIS EIGER2 X 16M |
Wavelength(s) | 1.033230 |
Spacegroup name | P 2 21 21 |
Unit cell lengths | 40.411, 82.784, 90.704 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 41.390 - 1.600 |
R-factor | 0.1902 |
Rwork | 0.190 |
R-free | 0.20310 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.005 |
RMSD bond angle | 0.858 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | PHENIX ((1.20.1_4487: ???)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 41.390 | 1.657 |
High resolution limit [Å] | 1.600 | 1.600 |
Number of reflections | 40806 | 3911 |
<I/σ(I)> | 17.54 | |
Completeness [%] | 99.5 | |
Redundancy | 2 | |
CC(1/2) | 1.000 | 0.773 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 7.5 | 293.15 | PEG 1000, PEG 3350, MPD, HEPES, MOPS, CHAPS, CHAPSO, Sodium glycocholate hydrate, Taurocholic acid sodium salt hydrate |